RTI, PierianDx Collaborate on Clinical Genomics Platform

Apr 17, 2018

|

NEW YORK (GenomeWeb) – RTI International and PierianDx today announced a strategic collaboration to accelerate the impact and adoption of PierianDx's genomics platform.

The collaboration includes an undisclosed investment and other strategic support to help advance PierianDx's growth plan, the firms said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

RTI, PierianDx Collaborate on Clinical Genomics Platform

To read the full story....

Breaking News

Somalogic Closes $121M Series A Funding

FDA Issues EUAs for Gravity Diagnostics Coronavirus Test, Sample Self-Collection Kit from RapidRona

Kantaro Biosciences Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

In Brief This Week: Quest Diagnostics, Fluidigm, BD, and More

Tempus Gets CE Mark for xT Tumor Sequencing Assay

BTIG Downgrades Fulgent Genetics from Buy to Neutral

What's Popular?

FDA Issues EUAs for Gravity Diagnostics Coronavirus Test, Sample Self-Collection Kit from RapidRona

BTIG Downgrades Fulgent Genetics from Buy to Neutral

Quest Diagnostics Enters Lab Services Agreement With Montefiore Nyack, Goshen Hospital

Abviris Developing Blood-Based Serology Test For HPV-Related Cancers

Kantaro Biosciences Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

Sponsorships